中/EN: 中文繁體 English

Investor Relations
IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
Corporate

Press Releases

2015

Please select

AUG
18

The United Laboratories International Holdings Limited Announces 2015 Interim Results, Profit from the Core Business Increased by 4.5% to Approximately HK$374.0 Million, Remarkable Sales Performance of Recombinant Human Insulin Injection Products, Steady Growth of Overseas Sales

MAR
31

The United Laboratories International Holdings Limited Announces 2014 Annual Results, Profit Attributable to Equity Holders Significantly Increased by 13.2 Times to HK$681 Million, Selling Prices of Intermediate and Bulk Medicine Products Continuously Increased Satisfactory Sales Performance of the Recombinant Human Insulin Products